Schrodinger, Inc. (SDGR) CEO exercises options and sells 86,000 shares
Rhea-AI Filing Summary
Schrodinger, Inc. President & CEO Ramy Farid reported option exercises and related share sales. He exercised stock options to acquire a total of 160,527 shares of common stock at an exercise price of $3.070 per share.
On April 16, 2026, he exercised options for 43,000 shares and sold 43,000 shares at a weighted average price of $12.331 per share. On April 17, 2026, he exercised additional options for 117,527 shares (in two tranches) and sold 43,000 shares at a weighted average price of $12.208 per share.
According to the filing, these transactions were effected under a Rule 10b5-1 trading plan adopted on September 2, 2025. After the transactions, Farid directly holds 330,824 shares of common stock, including 132,634 unvested RSUs, and the reported option grant from May 11, 2016 is fully vested and now exercised.
Positive
- None.
Negative
- None.
Insights
CEO executes pre-planned option exercises and partial share sales, retaining a substantial equity stake.
Ramy Farid, President & CEO of Schrodinger, Inc., exercised stock options covering 160,527 shares of common stock at an exercise price of $3.070 per share. The options were originally granted on May 11, 2016 and are fully vested, so this represents monetizing an established award rather than a new grant.
He sold a total of 86,000 shares in open-market transactions: 43,000 shares at a weighted average price of $12.331 on April 16, 2026, and 43,000 shares at a weighted average price of $12.208 on April 17, 2026. The filing states these trades were executed under a Rule 10b5-1 trading plan adopted on September 2, 2025, indicating they were pre-scheduled.
Following the transactions, Farid directly holds 330,824 shares of common stock, including 132,634 unvested RSUs, and there are no remaining options from the reported grant in the derivative summary. This pattern fits a typical exercise-and-sell sequence for liquidity while maintaining a significant ongoing equity position. Overall, the activity appears routine and does not materially alter the investment thesis.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 43,000 | $0.00 | -- |
| Exercise | Stock Option (right to buy) | 74,527 | $0.00 | -- |
| Exercise | Common Stock | 43,000 | $3.07 | $132K |
| Sale | Common Stock | 43,000 | $12.208 | $525K |
| Exercise | Common Stock | 74,527 | $3.07 | $229K |
| Exercise | Stock Option (right to buy) | 43,000 | $0.00 | -- |
| Exercise | Common Stock | 43,000 | $3.07 | $132K |
| Sale | Common Stock | 43,000 | $12.331 | $530K |
Footnotes (1)
- These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.80 to $12.79, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote(2) of this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.66 to $12.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote(3) of this Form 4. Includes 132,634 unvested RSUs. The option was granted on May 11, 2016 and is fully vested.